Search - tctmd.com

Displaying 481 - 500 of 688

Sort: Relevancy | Date

Presentation TCT 2014

Access Site and the Risk of Acute Kidney Injury

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Hitinder S. Gurm

September 16, 2014

Presentation TCT 2014

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Clinical Trial Updates: RenalGuard, AVERT, etc.

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon

September 16, 2014

Presentation TCT 2014

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

Presenter: Antonio L. Bartorelli, Somjot S. Brar, Roxana Mehran, Richard Solomon, Carlo Briguori

September 16, 2014

Presentation TCT 2014

ASD/VSD Technical Steps in Management

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab

September 16, 2014

Presentation TCT 2014

TAVR Gulf Experience and a Difficult TAVR Case

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab, Mohammed Balghith

September 16, 2014

Presentation TCT 2014

BVS in ACS

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab, Mohammad Al-Mutairi

September 16, 2014

Presentation TCT 2014

BVS Gulf Experience and a Complex BVS Implant

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab, Arif Al Nooryani

September 16, 2014

Presentation TCT 2014

Difficult Bifurcation Lesion Decisions

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab

September 16, 2014

Presentation TCT 2014

Hemodynamic Support in Complex PCI

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab, Ahmed Magdy

September 16, 2014

Presentation TCT 2014

Difficult Primary PCI Decisions

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab

September 16, 2014

Presentation TCT 2014

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

Presenter: Ori Ben-Yehuda, Harvey D. White, Roxana Mehran

September 15, 2014

Presentation TCT 2014

Intravenous HDL to Regress Plaque

Presenter: Ori Ben-Yehuda, Harvey D. White, Roxana Mehran

September 15, 2014

Presentation TCT 2014

PCSK9 Inhibitors: Comparison of Agents and a Systematic Review

Presenter: Ori Ben-Yehuda, Harvey D. White, Roxana Mehran, Evan A. Stein

September 15, 2014

Presentation TCT 2014

Innovative Technologies to Reduce and Monitor Contrast Dosage During Angiography

Presenter: Chaim S. Lotan, Julio C. Palmaz, Mark A. Turco, Roxana Mehran

September 15, 2014

Presentation TCT 2014

Statistical and Regulatory Challenges with Big Data and National Registries: Is Propensity Adjustment Enough? FDA Considerations

Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Gregory Campbell

September 15, 2014

Presentation TCT 2014

Are We Ready for Radical Changes in Medical Device Clinical Trial Designs?

Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Robert M. Califf

September 15, 2014

Presentation TCT 2014

CDRH Efforts to Improve the Ecosystem for Clinical Trials

Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Owen Faris

September 15, 2014

Presentation TCT 2014

Keynote Lecture II: Clinical Research in the United States Current Realities and How the Tide Can Turn

Presenter: Matthew G. Hillebrenner, Roxana Mehran, Aaron V. Kaplan, Robert A. Harrington

September 15, 2014

Presentation TCT 2014

SECURITY: A Prospective, Randomized Trial of Six Months Versus 12 Months of Dual Antiplatelet Therapy Following Coronary Drug-Eluting Stent Implantation

Presenter: Roxana Mehran, Harvey D. White, Antonio Colombo

September 15, 2014

Advertisement

Access Site and the Risk of Acute Kidney Injury

Flash Debate: Statins for Contrast Nephropathy Prevention Ready for Prime Time? Con!

Clinical Trial Updates: RenalGuard, AVERT, etc.

Intravenous and Oral Hydration to Prevent Contrast Nephropathy

ASD/VSD Technical Steps in Management

TAVR Gulf Experience and a Difficult TAVR Case

BVS in ACS

BVS Gulf Experience and a Complex BVS Implant

Difficult Bifurcation Lesion Decisions

Hemodynamic Support in Complex PCI

Difficult Primary PCI Decisions

LpPLA2 Inhibition by Darapladib in Coronary Artery Disease: Game Over or Just Beginning?

Intravenous HDL to Regress Plaque

PCSK9 Inhibitors: Comparison of Agents and a Systematic Review

Innovative Technologies to Reduce and Monitor Contrast Dosage During Angiography

Statistical and Regulatory Challenges with Big Data and National Registries: Is Propensity Adjustment Enough? FDA Considerations

Are We Ready for Radical Changes in Medical Device Clinical Trial Designs?

CDRH Efforts to Improve the Ecosystem for Clinical Trials

Keynote Lecture II: Clinical Research in the United States Current Realities and How the Tide Can Turn

SECURITY: A Prospective, Randomized Trial of Six Months Versus 12 Months of Dual Antiplatelet Therapy Following Coronary Drug-Eluting Stent Implantation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content